Vanda wins denial of petition for rehearing on Fanapt®
Vanda Pharmaceuticals announced the U.S. Court of Appeals for the Federal Circuit denied petitions for panel rehearing and rehearing en banc filed by West-Ward Pharmaceuticals, a subsidiary of Hikma Pharmaceuticals, relating to Vanda's U.S. Patent number 8,586,610 for Fanapt®. August 14, 2018